Clinical research progresss of antiviral drugs for the novel coronavirus pneumonia / 中华实验和临床病毒学杂志
Chinese Journal of Experimental and Clinical Virology
; (6): E001-E001, 2020.
Article
em Zh
| WPRIM
| ID: wpr-811588
Biblioteca responsável:
WPRO
ABSTRACT
The novel coronavirus (2019-nCoV or SARS-CoV-2) is a highly contagious and deadly virus that has infected more than 50 000 people and killed more than 1 000 people in 25 countries around the world. People who infected by the novel coronavirus may suffer from fever and cough, some may gradually appear breathing difficulties and other serious manifestations, some severe patients may have acute respiratory distress syndrome and septic shock leading to death. However, there are no definite and effective antiviral drugs for the novel coronavirus pneumonia all around the world. Therefore, this article aims to provide new idea for the effective treatment of the novel coronavirus pneumonia by summarizing the basic research and clinical progress of antiviral drugs at home and abroad.
Texto completo:
1
Base de dados:
WPRIM
Idioma:
Zh
Ano de publicação:
2020
Tipo de documento:
Article